切换至 "中华医学电子期刊资源库"

中华产科急救电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 198 -202. doi: 10.3877/cma.j.issn.2095-3259.2017.04.002

所属专题: 专题评论 文献

专家论坛

妊娠期肝衰竭母儿预后的评估
尹玉竹1,(), 张培珍1   
  1. 1. 510630 广州,中山大学附属第三医院产科
  • 收稿日期:2017-07-14 出版日期:2017-11-18
  • 通信作者: 尹玉竹

Prognostic assessment of mother and infant in live failure during pregnancy

Yuzhu Yin1(), Peizhen Zhang1   

  • Received:2017-07-14 Published:2017-11-18
  • Corresponding author: Yuzhu Yin
引用本文:

尹玉竹, 张培珍. 妊娠期肝衰竭母儿预后的评估[J/OL]. 中华产科急救电子杂志, 2017, 06(04): 198-202.

Yuzhu Yin, Peizhen Zhang. Prognostic assessment of mother and infant in live failure during pregnancy[J/OL]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2017, 06(04): 198-202.

妊娠期肝衰竭病情凶险,孕妇和胎儿死亡率高。乙型肝炎病毒感染和妊娠期急性脂肪肝是导致我国妊娠期肝衰竭的主要原因,有效的病情评估和及时终止妊娠是改善母儿预后的主要手段。终末期肝病模型评分、肝功能CTP评分和Swansea标准对急慢性肝衰竭和妊娠期急性脂肪肝预后有一定的评估价值,但尚需在临床工作中进一步探讨。

Live failure during pregnancy often evolves critically and carries out high maternal-fetus mortality. Infection of hepatitis B virus and acute fatty liver of pregnancy (AFLP) are the most common causes of liver failure during pregnancy in China. Prognosis can be improved with effective evaluation of illness state and timely termination of pregnancy. The model for end-stage liver disease (MELD) scoring system, Child-Turcotte-Pugh (CTP) scoring system of liver function and Swansea criteria can be used to predicting the prognosis of acute-chronic hepatitis B liver failure and AFLP, but it should be further explored in clinical work.

表1 CTP评分系统[20]
[1]
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版)[J]. 中华临床感染病杂志,2012, 5(6):321-327.
[2]
曹健英,陈宝花,蒋佩茹. 妊娠合并肝衰竭患者的病死危险因素分析[J]. 现代妇产科进展,2013, 22(9):730-733.
[3]
Li XM, Deng LZ, Shen HM, et al. Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis[J]. Chin Med J (Engl), 2007, 120(24):2311-2313.
[4]
Knox TA, Olans LB. Liver disease in pregnancy[J]. N Engl J Med, 1996, 335(8):569-576.
[5]
Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy[J]. The Lancet, 2010, 375(9714):594-605.
[6]
Than NN, Neuberger J. Liver abnormalities in pregnancy[J]. Best Pract Res Clin Gastroenterol, 2013, 27(4):565-575.
[7]
Jena P, Sheela CN, Venkatachala RP, et al. Obstetric outcome in women with chronic liver disease[J]. J Obstet Gynaecol India, 2017, 67(4):263-269.
[8]
Shaheen AA, Myers RP. The outcomes of pregnancy in patients with cirrhosis: a population-based study[J]. Liver Int, 2010, 30(2):275-283.
[9]
Ko H, Yoshida EM. Acute fatty liver of pregnancy[J]. Can J Gastroenterol, 2006, 20(1):25-30.
[10]
13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure[J]. Hepatobiliary Pancreat Dis Int, 2013, 12(4):346-354.
[11]
Ding G, Li Z, Zhang L, et al. Circulating full-length cytokeratin 18 for predicting prognosis of hepatitis B virus-related acute-on-chronic liver failure patients with lamivudine treatment[J]. Hepatol Res, 2016, 46(4):329-334.
[12]
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
[13]
Kamath PS, Kim WR. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3):797-805.
[14]
Zheng MH, Shi KQ, Fan YC, et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure[J]. Clin Gastroenterol Hepatol, 2011, 9(4):351-356.
[15]
于琳,曾荔苹,光晓燕. 妊娠合并重型肝炎患者MELD评分分析与终止妊娠时机[J]. 现代中西医结合杂志,2010, 19(5):524-525, 528.
[16]
杨越波,邓柳枝,李小毛. MELD评分对晚期妊娠合并重型肝炎预后的评价作用[C]. 南京:第二届围产医学新进展高峰论坛,2010.
[17]
Sun QF, Ding JG, Xu DZ, et al. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model[J]. J Viral Hepat, 2009, 16(7):464-470.
[18]
Xu X, Liu X, Ling Q, et al. Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure[J]. PLoS One, 2013, 8(3):e58738.
[19]
Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2006, 55 Suppl 6:i1-i12.
[20]
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60:646-649.
[21]
谢仕斌,吴元凯,朱建芸,等. 慢加急性肝衰竭预后评分系统的建立与评估[J]. 中山大学学报(医学科学版), 2011, 32(6):834-840.
[22]
Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK[J]. Gut, 2008, 57(7):951-956.
[23]
Goel A, Ramakrishna B, Zachariah U, et al. How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis?[J]. Gut, 2011, 60(1):138-139, 139-140.
[24]
Meng J, Wang S, Gu Y, et al. Prenatal predictors in postpartum recovery for acute fatty liver of pregnancy: experiences at a tertiary referral center[J]. Arch Gynecol Obstet, 2016, 293(6):1185-1191.
[25]
Holt EW, Guy J, Gordon SM, et al. Acute liver failure caused by herpes simplex virus in a pregnant patient: is there a potential role for therapeutic plasma exchange?[J]. J Clin Apher, 2013, 28(6):426-429.
[26]
Qu YY, Zeng H, Guo XY, et al. Retrospective analysis of anesthetic and perioperative management in patients of acute fatty liver of pregnancy[J]. Zhonghua Yi Xue Za Zhi, 2017, 97(24):1878-1882.
[27]
Yu CB, Chen JJ, Du WB, et al. Effects of plasma exchange combined with continuous renal replacement therapy on acute fatty liver of pregnancy[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(2):179-183.
[28]
Papafragkakis H, Singhal S, Anand S. Acute fatty liver of pregnancy[J]. South Med J, 2013, 106(10):588-593.
[29]
Zhou G, Zhang X, Ge S. Retrospective analysis of acute fatty liver of pregnancy: twenty-eight cases and discussion of anesthesia[J]. Gynecol Obstet Invest, 2013, 76(2):83-89.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[10] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[11] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[12] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?